What is Geltor?
Headquartered in San Leandro, California, Geltor operates at the intersection of biology and material science. The company specializes in the development of designer proteins that offer superior biocompatibility, functionality, and performance compared to conventional animal-derived ingredients. By utilizing a proprietary bio-design platform, Geltor produces 100% animal-free proteins that are sustainably cultivated, catering to a growing consumer base that prioritizes ethical sourcing and environmental impact. Their products are clinically demonstrated to meet high-performance standards, making them a critical supplier for industries ranging from personal care to food and beverage. As a leader in the bio-design space, Geltor is redefining the supply chain for essential proteins, moving away from resource-intensive agricultural practices toward a more efficient, technology-driven model.
How much funding has Geltor raised?
Geltor has raised a total of $109.5M across 2 funding rounds:
Series A
$18.2M
Series B
$91.3M
Series A (2018): $18.2M with participation from GELITA, Cavallo Ventures, BoxGroup, Cultivian Sandbox Ventures, and ADM Ventures
Series B (2020): $91.3M led by CPT Capital, WTT Investment, RIT Capital Partners, Pegasus Tech Ventures, Blue Horizon Ventures, Cultivian Sandbox, Humboldt Fund, SOSV, and iSelect Fund Management
Key Investors in Geltor
RIT Capital Partners
A publicly traded investment firm based in London that focuses on long-term capital growth through diversified investments in both public and private markets.
Cultivian Sandbox
A venture capital firm dedicated to investing in innovative food and agriculture technology companies that promote sustainability and security in the global food system.
SOSV
A multi-stage venture capital investor that provides both intellectual and financial capital to accelerate the growth of high-potential startups.
What's next for Geltor?
Looking ahead, Geltor is poised to leverage its recent capital infusion to accelerate the commercialization of its protein portfolio. The strategic focus will likely center on scaling production capacity to meet the rising demand for sustainable ingredients across global markets. Furthermore, the company is expected to deepen its research and development efforts, exploring new protein structures that can address specific functional needs in the beauty, nutrition, and food sectors. With a robust foundation of institutional support, Geltor is well-positioned to maintain its competitive edge as a leader in the bio-design revolution, potentially exploring new partnerships that could further integrate its technology into mainstream consumer products.
See full Geltor company page
